Abstract:IntroductionEsophageal cancer (EC) is the eighth most common cancer and the sixth most common cause of cancer death worldwide.Esophageal squamous cell carcinoma (ESCC) and adenocarcinoma (EAC) are two major histopathological type of esophageal cancer.The incidence of EC was increased in the past 3 decades.Five-year survival of advanced cancer is still very poor, even though improved surgical techniques and adjuvant chemoradiation therapy.It is very important to understand esophageal cancer biology. Genetic changes in esophageal cancerGenetic change is one of the major events in transforming normal esophageal epithelia to malignant cells.Mutations and genetic polymorphisms in coding gene sequences may cause functional alteration of genes.Functional mutation and single nucleotide polymorphism (SNP) (eg.p53,SULT1A1, CYP3A5, ALDH2, ADH1B1 and ECRG1) is related to susceptibility of esophageal cancer. Effects of mutations and SNPs in esophageal cancerP53 is involved in multiple cellular pathways including apoptosis, transcriptional regulation, and cell cycle control.Alterations in p53 have been reported to occur at an early stage of EC.P53 mutation was observed in exon 5 and accounted for about 77% of ESCC patients (Hu, Huang et al., 2001).Fanconi gene family is another interesting example.The risk of ESCC is associated with both heterozygous and homozygous mutations in several Fanconi anemia-predisposing genes, such as heterozygous insertion/deletion mutations in FANCD2 (p.Val1233-del), FANCE (p.Val311SerfsX2) and FANCL (p.Thr367AsnfsX13) (Akbari et al., 2011).SNPs in p53 pathway also play important roles in EC tumorigenesis.SNP in p53 gene (Arg72Pro) decreased apoptosis and was associated with increased risk, earlier age of onset, reduced response to chemotherapy and early recurrence in esophageal cancers (Pietsch et al., 2006).T309G is located in the promoter region of MDM2, which is the regulator of p53 pathway.Transcription factor may easily bind to the G variant of MDM2, increase MDM2 www.intechopen.comEsophageal Cancer -Cell and Molecular Biology, Biomarkers, Nutrition and Treatment 2 expression and reduce apoptosis in response to DNA damage (Bond et al., 2004).MDM2 T309G G/G was associated with an increased risk of death in ESCC (Cescon et al., 2009).SNPs in key genes are associated with EC, such as genes involved in nucleotide excision repair (NER) and base excision repair (BER) pathways.The increasing number of variant alleles in SNPs of NER showed a significant trend to EAC, including XPD Lys751Gln, ERCC1 8092 C/A and ERCC1 118C/T (Tse et al., 2008).Esophageal cancer related gene 1 (ECRG1) is reported as a novel tumor suppressor.ECRG1 is normally expressed in esophagus, but reduced in ESCC.ECRG1 (Arg290Gln) was identified as the susceptible SNP of ESCC (Li et al., 2006).It has been found that the increased risk of ESCC relates to combined SULT1A12*2 genotype and CYP3A5 heterozygous genotypes, especially in tobacco smokers (Dandara et al., 2006).SNP of ATP-binding cassette sub-family B (MDR/TAP) member 1 gene (ABCB1) was reported to be associated with lymph node and distant metastases in EC (Narumiya et al., 2011).SNP also impacted disease-free survival (DFS) of ECs.The MDM2 T/G and CDH1 GA/GA genotype confer risk of death in EAC patients (Boonstra et al., 2011).Vascular endothelial growth factor (VEGF) 936C/T is associated with an improved overall survival compared with wild type genotype in EC (Bradbury et al., 2009). Effects of chromosomal abnormalities in esophageal cancerGenomic alterations, such as amplification, deletion, translocation and loss of heterozygosity (LOH) play an important role in initiation and progression of cancer.Recently a panel of chromosome instability biomarkers, including LOH and DNA content, has been reported to identify patients at high and low risk of progression from Barrett's esophagus (BE) to EAC (Paulson et al., 2009).

Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer

Abstract 1745: Targeting therapeutic resistance of esophageal adenocarcinoma through modulating the epithelial-to-mesenchymal transition via NFκB-mediated signaling

Abstract A002: Serum Biomarkers of VEGF-A and TGF-β1 Predict Pathological Response and Survival of Esophageal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy and Esophagectomy

Abstract 3604: Identification of genes involved in pathogenesis of esophageal adenocarcinoma using RNA sequencing from laser capture micro-dissected formalin-fixed paraffin-embedded tissue specimens

Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to Adenocarcinoma

Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma

Biomarker Identification and Trans-Regulatory Network Analyses in Esophageal Adenocarcinoma and Barrett's Esophagus.

Abstract 2005: the Evolutionarily Conserved Gene Expression Signatures SPARC and SPP1 Are Genetic Determinants of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma

IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment

Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinoma

Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development

Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma

TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines

Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival

High Content Imaging of Barrett's-Associated High-Grade Dysplasia Cells After siRNA Library Screening Reveals Acid-Responsive Regulators of Cellular Transitions

Data from Targeting NF-κB Signaling Pathway Suppresses Tumor Growth, Angiogenesis, and Metastasis of Human Esophageal Cancer

Molecular Biology Character of Esophageal Cancer

Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome.

Integrated Analysis Of Escc Tumor/Normal Tissues And Patient Blood Samples Using Expression, Genotypes And Dna Somatic Change Data

Metabolic Remodeling by TIGAR Overexpression is a Therapeutic Target in Esophageal Squamous-Cell Carcinoma